Adaptimmune Therapeutics Plc PEG
Qual é o PEG de Adaptimmune Therapeutics Plc?
O PEG de Adaptimmune Therapeutics Plc é N/A
Qual é a definição de PEG?
A razão preço/lucro para crescimento (PEG) é o rácio P/L de uma ação dividido por uma taxa de crescimento prevista dos seus ganhos durante um período de 5 anos.
The PEG ratio is calculated by dividing the P/E ratio by the company's expected earnings growth rate in the next 5 years. Since using just the P/E ratio would make high-growth companies appear overvalued relative to others, the PEG ratio is considered to be a convenient approximation. PEG is a widely employed indicator of a stock's possible true value.
Similar to P/E ratios, a lower PEG means that the stock is undervalued more. It is favored by many over the price/earnings ratio because it also accounts for growth. The PEG ratio of 1 is sometimes said to represent a fair trade-off between the values of cost and the values of growth, indicating that a stock is reasonably valued given the expected growth. A crude analysis suggests that companies with PEG values between 0 and 1 may provide higher returns. A PEG Ratio can also be a negative number if a stock's present income figure is negative, (negative earnings) or if future earnings are expected to drop (negative growth). PEG ratios calculated from negative present earnings are viewed with skepticism as almost meaningless, other than as an indication of high investment risk.
PEG de empresas na Setor Health Care em NASDAQ em comparação com Adaptimmune Therapeutics Plc
O que Adaptimmune Therapeutics Plc faz?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.
Empresas com peg semelhantes a Adaptimmune Therapeutics Plc
- Ecopetrol SA tem PEG de N/A
- Medley Capital Corp tem PEG de N/A
- AGNC Investment Corp tem PEG de N/A
- Liberty Media tem PEG de N/A
- Acacia Communications Inc tem PEG de N/A
- Smart Sand Inc tem PEG de N/A
- Adaptimmune Therapeutics Plc tem PEG de N/A
- TeraGo tem PEG de N/A
- Kennametal tem PEG de N/A
- Telstra tem PEG de N/A
- Oracle Services Software tem PEG de N/A
- Hecla Mining Co tem PEG de N/A
- Kirkland`s Inc tem PEG de N/A